Bupropion
| Bupropion | |
|---|---|
| Salts [] | |
|---|---|
| Bupropion hydrobromide | |
| Bupropion hydrochloride | |
| Bupropion maleate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 239.74 g/mol [1] |
| Appearance | Pale yellow oil [1] |
| Melting point | 233-234 °C [1] |
| Boiling point | BP: 52 °C at 0.005 mm Hg [1] |
| Solubility | 312 mg/ml [1] |
| Predicted LogP | 3.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H18ClNO |
| IUPAC name | 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one |
| SMILES | CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C |
| InChI | InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 |
| InChIKey | SNPPWIUOZRMYNY-UHFFFAOYSA-N |
| CAS number | 34911-55-2 |
| UNII | 01ZG3TPX31 |
| PubChem CID | 444 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | * Bupropion: ** alpha: 0.5–1.04 ** beta: 11 h * Hydroxybupropion: 20 h * Threohydrobupropion: 37 h * Erythrohydrobupropion: 33 h |
| Metabolism | Liver, intestines (CYP2B6, others) |
| Routes of administration | Oral |
| Addiction liability | Low[3] |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - ip: 230 mg/kg - oral: 575 mg/kg Rat: - ip: 210 mg/kg - oral: 600 mg/kg [1] |
| Dosing[] |
|---|
| Intravenous [] | |
|---|---|
| Light | ≤ 43.1 mg(3x - 30.0%) |
| Common | 43.1 - 50 mg(4x - 40.0%) |
| Strong | 50 - 57.5 mg |
| Heavy | 57.5 - 74.4 mg(1x - 10.0%) |
| Extreme | 74.4 mg +(2x - 20.0%) |
| Oral [] | |
|---|---|
| Light | ≤ 200 mg(94x - 40.7%) |
| Common | 200 - 300 mg(136x - 58.9%) |
| Strong | 300 mg |
| Heavy | 300 mg |
| Extreme | 300 mg +(1x - 0.4%) |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Bupropion (also known as Amfebutamone, Amfebutamon, amfebutamonum, Amfebutamona, (+-)-Bupropion, Elontril, Bupropion slow release, bupropione, Bupropion extended release or α-(tert-butylamino)-m-chloropropiophenone) is a antidepressant, depressant and stimulant substance of the cathinone class.
Chemistry
Salts []
Stereochemistry []
Bupropion is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Bupropion matches Lipinski's rule of five.Reagents
There are currently 4 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change | |
| Zimmermann | no change / faint yellow |
Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- antidepressants (N06A)
- other antidepressants (N06AX)
- (N06AX12)
- bupropion (N06AX12)
MeSH Classification
- smoking cessation agents (M000640785)
- antidepressive agents, second-generation (M0028000)
- dopamine uptake inhibitors (M0028098)
- cytochrome p-450 cyp2d6 inhibitors (M0590381)
Mechanism of action []
Bupropion is a norepinephrine/dopamine-reuptake inhibitor (NDRI) that exerts its pharmacological effects by weakly inhibiting the enzymes involved in the uptake of the neurotransmitters norepinephrine and dopamine from the synaptic cleft, therefore prolonging their duration of action within the neuronal synapse and the downstream effects of these neurotransmitters. More specifically, bupropion binds to the norepinephrine transporter (NET) and the dopamine transporter (DAT). Bupropion was originally classified as an "atypical" antidepressant because it does not exert the same effects as the classical antidepressants such as Monoamine Oxidase Inhibitors (MAOIs), Tricyclic Antidepressants (TCAs), or Selective Serotonin Reuptake Inhibitors (SSRIs). While it has comparable effectiveness to typical first-line options for the treatment of depression such as SSRIs, bupropion is a unique option for the treatment of MDD as it lacks any clinically relevant serotonergic effects, typical of other mood medications, or any effects on histamine or adrenaline receptors. Lack of activity at these receptors results in a more tolerable side effect profile; bupropion is less likely to cause sexual side effects, sedation, or weight gain as compared to SSRIs or TCAs, for example. When used as an aid to smoking cessation, bupropion is thought to confer its anti-craving and anti-withdrawal effects by inhibiting dopamine reuptake, which is thought to be involved in the reward pathways associated with nicotine, and through the antagonism of the nicotinic acetylcholinergic receptor (AChR), thereby blunting the effects of nicotine. Furthermore, the stimulatory effects produced by bupropion in the central nervous system are similar to nicotine's effects, making low doses of bupropion a suitable option as a nicotine substitute. When used in combination with [naltrexone] in the marketed product ContraveⓇ for chronic weight management, the two components are thought to have effects on areas of the brain involved in the regulation of food intake. This includes the hypothalamus, which is involved in appetite regulation, and the mesolimbic dopamine circuit, which is involved in reward pathways. Studies have shown that the combined activity of bupropion and [naltrexone] increase the firing rate of hypothalamic pro-opiomelanocortin (POMC) neurons and blockade of opioid receptor-mediated POMC auto-inhibition, which are associated with a reduction in food intake and increased energy expenditure. This combination was also found to reduce food intake when injected directly into the ventral tegmental area of the mesolimbic circuit in mice, which is an area associated with the regulation of reward pathways. [1]
Metabolism
Bupropion acts as a prodrug for:
| Metabolic pathways [] |
|---|
Prodrugs of bupropion: N-Methylbupropion.
Medical side effects []
489 side effects listed on drug labels in SIDER 4.1 (bupropion).
- Nervous system disorder
- Headache
- Gastrointestinal disorder
- Digestion impaired
- Dry mouth
- Weight decreased
- Hyperhidrosis
- Sweating
- Insomnia
- Difficulty sleeping
- Application site reaction
- Weight increased
- Nasopharyngitis
- Rhinorrhoea
- Nausea
- Rhinitis
- Constipation
- Upper respiratory tract infection
- Confusional state
- Feeling abnormal
- Malaise
- Infection
- Dizziness
- Syncope
- Bradykinesia
- Diarrhoea
- Loose stools
- Anxiety
- Flatulence
- Tinnitus
- Arrhythmia
- Hearing impaired
- Decreased appetite
- Appetite absent
- Asthenia
- Fatigue
- Myoclonus
- Nocturia
- Convulsion
- Mania
- Manic psychosis
- Influenza like illness
- Sexual dysfunction
- Cough
- Cough increased
- Mediastinal disorder
- Vomiting
- Sensory disturbance
- Malnutrition
- Palpitations
- Increased appetite
- Dyspepsia
- Influenza
- Disturbance in attention
- Impairment of attention
- Mental disability
- Thinking abnormal
- Abdominal pain
- Gastrointestinal pain
- Chest pain
- Chest discomfort
- Dermatitis
- Rash
- Nervousness
- Feeling jittery
- Tension
- Pain in extremity
- Pharyngitis
- Sinusitis
- Tremor
- Shakiness
- Skin disorder
- Abnormal dreams
- Vision blurred
- Pollakiuria
- Micturition urgency
- Amblyopia
- Pruritus
- Arthritis
- Breast disorder
- Diplopia
- Dysgeusia
- Dysmenorrhoea
- Irritability
- Pain
- Angiopathy
- Agitation
- Hyperkinesia
- Injury
- Myalgia
- Musculoskeletal discomfort
- Arthralgia
- Somnolence
- Muscle spasms
- Cramps of lower extremities
- Cramp muscle
- Migraine
- Akathisia
- Parkinsonism
- Neck pain
- Flushing
- Hypersensitivity
- Paraesthesia
- Urticaria
- Muscle twitching
- Menopausal symptoms
- Hot flush
- Vaginal haemorrhage
- Hypertension
- Back pain
- Bronchitis
- Bruxism
- Libido decreased
- Disturbance in sexual arousal
- Libido increased
- Dysphagia
- Depersonalisation
- Dyspnoea
- Oedema
- Female sexual arousal disorder
- Gastrooesophageal reflux disease
- Gingivitis
- Inguinal hernia
- Hostility
- Jaundice
- Polyuria
- Urine output increased
- Psychotic disorder
- Paranoia
- Stomatitis
- Mouth ulceration
- Tachycardia
- Thirst
- Toothache
- Urinary tract infection
- Vertigo
- Chills
- Rigors
- Mood swings
- Affect lability
- Hepatic function abnormal
- Dry skin
- Dysphoria
- Memory impairment
- Erectile dysfunction
- Dry eye
- Keratoconjunctivitis sicca
- Photosensitivity reaction
- Sunburn
- Coordination abnormal
- Visual impairment
- Vulvovaginal discomfort
- Gingival pain
- Paranoid reaction
- Testicular swelling
- Face oedema
- Aggression
- Alopecia
- Amnesia
- Anaemia
- Angioedema
- Aphasia
- Ataxia
- Bronchospasm
- Cardiovascular disorder
- Colitis
- Coma
- Cystitis
- Bladder pain
- Cystitis noninfective
- Deafness
- Delirium
- Delusion
- Dermatitis exfoliative
- Dysarthria
- Osteoarthritis
- Dyskinesia
- Dysuria
- Ecchymosis
- Enuresis
- Epistaxis
- Erythema multiforme
- Stevens-Johnson syndrome
- Oesophagitis
- Extrapyramidal disorder
- Body temperature increased
- Gastrointestinal haemorrhage
- Gingival bleeding
- Angle closure glaucoma
- Glossitis
- Glycosuria
- Gynaecomastia
- Hallucination
- Hepatitis
- Hirsutism
- Hyperglycaemia
- Type IV hypersensitivity reaction
- Hypoaesthesia
- Hypoglycaemia
- Hypotension
- Orthostatic hypotension
- Inappropriate antidiuretic hormone secretion
- Intestinal perforation
- Leukocytosis
- Leukopenia
- Menopause
- Hypertonia
- Muscle rigidity
- Mydriasis
- Myocardial infarction
- Acute coronary syndrome
- Neuralgia
- Ovarian disorder
- Pallor
- Pancreatitis
- Pancytopenia
- Pelvic infection
- Phlebitis
- Pneumonia
- Prostatic disorder
- Pulmonary embolism
- Rhabdomyolysis
- Salpingitis
- Sciatica
- Serum sickness
- Salivary hypersecretion
- Gastric ulcer
- Cerebrovascular accident
- Suicide attempt
- Shock
- Loss of consciousness
- Thrombocytopenia
- Urinary incontinence
- Urethral disorder
- Urinary tract disorder
- Vaginal inflammation
- Vaginal infection
- Vaginitis bacterial
- Vasodilation procedure
- Urinary retention
- Skin odour abnormal
- Akinesia
- Oedema peripheral
- Hypokinesia
- Atrioventricular block complete
- Tongue disorder
- Tongue oedema
- Electroencephalogram abnormal
- Hepatocellular injury
- Liver injury
- Muscular weakness
- Discomfort
- Ill-defined disorder
- Derealisation
- Painful erection
- Intraocular pressure increased
- Euphoric mood
- Swollen tongue
- Hypomania
- Painful ejaculation
- Extrasystoles
- Rash maculo-papular
- Suicidal ideation
- Neuropathy peripheral
- Hair colour changes
- Musculoskeletal chest pain
- Chest wall pain
- Lymphadenopathy
- Tardive dyskinesia
- Completed suicide
- Suicide
- Neurological examination abnormal
- Dyspareunia
- Ejaculation disorder
- Abdominal distension
- Amenorrhoea
- Anaphylactic shock
- Anger
- Asthma
- Back injury
- Mental disorder
- Bipolar disorder
- Bipolar I disorder
- Concussion
- Breast cancer
- Bursitis
- Basal cell carcinoma
- Carpal tunnel syndrome
- Pleuritic pain
- Conjunctivitis
- Connective tissue disorder
- Contusion
- Cyst
- Dehydration
- Dental caries
- Dermatitis atopic
- Drug abuse
- Drug hypersensitivity
- Ear pain
- Eczema
- Epicondylitis
- Eructation
- Excoriation
- Eye disorder
- Flank pain
- Vitreous floaters
- Cardiac flutter
- Localised infection
- Folliculitis
- Food allergy
- Food poisoning
- Gastritis
- Gastroenteritis
- Breath odour
- Seasonal allergy
- Rhinitis seasonal
- Cardiac disorder
- Haemorrhage
- Haemoglobin
- Hepatitis C
- Herpes zoster
- Herpes virus infection
- Hordeolum
- Hunger
- Hypercholesterolaemia
- Breast enlargement
- Hyperventilation
- Hypotrichosis
- Immune system disorder
- Laryngitis
- Lethargy
- Menstrual disorder
- Metrorrhagia
- Motion sickness
- Hypotonia
- Muscle relaxant therapy
- Musculoskeletal disorder
- Musculoskeletal pain
- Fungal infection
- Nasal congestion
- Neoplasm
- Night sweats
- Nightmare
- Orgasm abnormal
- Osteoporosis
- Ovarian cyst
- Panic reaction
- Sinus disorder
- Polyp
- Pregnancy
- Premenstrual syndrome
- Prurigo
- Tension headache
- Hyperacusis
- Respiratory tract infection
- Sebaceous gland disorder
- Pharyngitis streptococcal
- Sinus headache
- Sinus pain
- Sleep disorder
- Sneezing
- Snoring
- Soft tissue injury
- Somnambulism
- Supraventricular tachycardia
- Tendonitis
- Testicular pain
- Tinea pedis
- Tonsillitis
- Tooth disorder
- Trichotillomania
- Micturition disorder
- Wheezing
- Wound infection
- Laceration
- Skin laceration
- Yawning
- Muscle strain
- Apathy
- Flat affect
- Photophobia
- Depressive symptom
- Panic attack
- Drug withdrawal syndrome
- Swelling face
- Impaired healing
- Hyperchlorhydria
- Gastric pH decreased
- Eye pain
- Sore eye
- Urethral pain
- Tendon disorder
- Duodenal ulcer haemorrhage
- Sinus congestion
- Skin irritation
- Joint swelling
- Lacrimation increased
- Viral diarrhoea
- Menstruation irregular
- Facial bones fracture
- Joint stiffness
- Oral pain
- Sore mouth
- Nasal dryness
- Cold sweat
- Abdominal pain upper
- Abdominal pain lower
- Disorientation
- Feeling of despair
- Perseveration
- Hallucination, auditory
- Rash erythematous
- Muscle contractions involuntary
- Poor quality sleep
- Abdominal discomfort
- Gastrointestinal discomfort
- Hepatotoxicity
- Lacrimation decreased
- Hepatic enzyme increased
- Pain in jaw
- Heart rate irregular
- Circumoral oedema
- Genital rash
- Frequent bowel movements
- Hyperaesthesia
- Nipple pain
- Prostate infection
- Dermal cyst
- Pulmonary congestion
- Respiratory tract congestion
- Breast tenderness
- Vocal cord disorder
- Mouth injury
- Nerve injury
- Nerve compression
- Peripheral coldness
- Viral upper respiratory tract infection
- Depressed mood
- Epigastric discomfort
- Initial insomnia
- Middle insomnia
- Joint injury
- Increased tendency to bruise
- Respiration abnormal
- Defaecation urgency
- Ligament sprain
- Wrist fracture
- Energy increased
- Pruritus generalised
- Dyslexia
- Conjunctivitis infective
- Blood pressure increased
- Tooth abscess
- Breast calcifications
- Paraesthesia oral
- Hypoaesthesia oral
- Stress
- Self-injurious ideation
- Terminal insomnia
- Altered state of consciousness
- Depressed level of consciousness
- Vulvovaginal mycotic infection
- Lip dry
- Renal pain
- Gastritis viral
- Rubber sensitivity
- Sensation of heaviness
- Ear infection
- Throat irritation
- Acne
- Limb injury
- Infestation
- Animal scratch
- Arthropod bite
- Feelings of worthlessness
- Social avoidant behaviour
- Laryngeal pain
- Tooth infection
- Injection site joint pain
- Procedural pain
- Muscle tightness
- Hypertonic bladder
- Hypersomnia
- Musculoskeletal stiffness
- Infrequent bowel movements
- Increased upper airway secretion
- Parosmia
- Lower limb fracture
- Feeling hot
Indications
- Agitation
- Bradypsychic response
- Cerebration impaired
- Chronic obstructive pulmonary disease
- Convulsion
- Convulsions generalised
- Decreased interest
- Depressed mood
- Depressive disorder
- Dysphoria
- Fatigability
- Fatigue
- Feeling guilty
- Hypersomnia
- Insomnia
- Major depression
- Major depressive disorder, single episode
- Mental disorder
- Nicotine dependence
- Seasonal affective disorder
- Sexual dysfunction
- Suicidal ideation
- Suicide attempt
Subjective effects []
| 0xea / Bupropion [] | |
|---|---|
Routes:
| |
| a1ko / Bupropion [] | |
|---|---|
Routes:
| |
| alina / Bupropion [] | |
|---|---|
Routes:
| |
| emily / Bupropion [] | |
|---|---|
Routes:
| |
| Pilz / Bupropion [] | |
|---|---|
Routes:
| |
Experience reports
- "Trip Report: The Most Profound & Horrifying Moment of My Life" by -Tierce27 (4 upvotes)
- "A Sensual Night in Ecstasy" by Public-Bobcat-814 (4 upvotes)
- "My most terrifying trip a dxm and bupropion combo" by Zhikzo (1 upvotes)
- "9/22/2021 pyra (xan like) and mph (methylphenidate like)" by WhatAHenk (0 upvotes)
Legal status []
- Australia: Bupropion is a Schedule 4.[4]
- Brazil: Bupropion is a C1.[5]
- Canada: Bupropion is Prescription only.[6][7]
- United Kingdom: Bupropion is Prescription only.[8]
- United States: Bupropion is Prescription only.[9]
- European Union: Bupropion is Prescription only.[10]
- Other: Bupropion is a SE: Rx-only, In general: Prescription only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 444, Bupropion. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/444
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bupropion. UNII: 01ZG3TPX31. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/01ZG3TPX31
Voxra (Tablett med modifierad frisättning 300 mg) • Produktresumé. FASS Vård. https://fass.se/health/product/20060308000083/smpc#:~:text=Data%20fr%C3%A5n%20djurstudier%20antyder%20en%20missbrukspotential.%20Studier%20av%20beroenderisk%20hos%20m%C3%A4nniska%2C%20liksom%20omfattande%20klinisk%20erfarenhet%2C%20visar%20emellertid%20att%20bupropion%20har%20l%C3%A5g%20missbrukspotential.
Australian product information: Zyban SR (bupropion hydrochloride) sustained release tablets. Therapeutic Goods Administration, Australian Government. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2013-PI-01138-1
RDC Nº 784 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Wellbutrin Product information. Health Canada. 25 April 2012. https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61183
Zyban Product information. Health Canada. 25 April 2012. https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61860
Zyban 150 mg prolonged release tablets – Summary of Product Characteristics (SmPC). Electronic Medicines Compendium. 21 April 2022. https://www.medicines.org.uk/emc/product/3827/smpc
Wellbutrin XL – bupropion hydrochloride tablet, extended release. DailyMed. 4 March 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21
Bupropion hydrochloride EPAR. European Medicines Agency (EMA). 17 September 2018. https://www.ema.europa.eu/en/medicines/human/referrals/bupropion-hydrochloride
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 08:42:14 |
| drugspro | ok | 2026-11-20 08:42:10 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:42:10 |
| gsrs | ok | 2026-11-20 08:42:13 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0001510) | 2026-11-20 08:42:10 |
| kegg | ok | 2026-11-20 08:42:13 |
| pubchem | ok | 2026-11-20 08:42:08 |
| ok | 2026-11-20 08:42:10 | |
| sider | ok | 2026-11-20 08:42:11 |
| structure | ok | 2026-11-20 08:42:10 |
| wikipedia | ok | 2026-11-20 08:42:11 |